Methylhexadeca-trans-2-trans-4-trans-6-trienoat | 67214-23-7

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: Methylhexadeca-trans-2-trans-4-trans-6-trienoat
• 英文别名: Hexadecatrienoic acid methyl ester labeled with carbon-13；methyl (2E,4E,6E)-hexadeca-2,4,6-trienoate
• CAS: 67214-23-7
• 化学式: C₁₇H₂₈O₂
• 分子量: 264.408
• InChiKey: LTSILXIATRERSU-UVKUXWPTSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.4
• 重原子数：
  19
• 可旋转键数：
  12
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.59
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  2-十二烯基苯基砜 在 对甲苯磺酸 正丁基锂 、 potassium tert-butylate 作用下， 以 苯 为溶剂， 反应 17.08h， 生成 Methylhexadeca-trans-2-trans-4-trans-6-trienoat
  参考文献：
  名称：

  通过双消除反应高度立体选择性地合成（2E，4E）-二酰胺和（2E，4E）-二烯酸酯

  摘要：

  通过（β-乙酰氧基）砜的双重消除反应实现了（2E，4E）-二酰胺和（2E，4E）-二烯酸酯的高度立体选择性合成。

  DOI：

  10.1016/s0040-4039(00)84052-6

文献信息

• [EN] CERAMIDE DERIVATIVES AS ANTICANCER AGENTS<br/>[FR] DÉRIVÉS DE CÉRAMIDE UTILISÉS EN TANT QU'AGENTS ANTICANCÉREUX
  申请人：UNIV RUTGERS

  公开号：WO2017015301A1

  公开（公告）日：2017-01-26

  The invention provides a compound of formula (I): (I) wherein R1-R4 have any of the values defined in the specification, as well as compositions comprising a compound of formula (I) and methods for treating diseases (e.g. cancer).

  该发明提供了一个式子为（I）的化合物：（I），其中R1-R4具有规范中定义的任何值，以及包含式子为（I）的化合物的组合物和用于治疗疾病（例如癌症）的方法。
• MANDAI, TADAKTSU;MORIYAMA, TADASHI;TSUJIMOTO, KOICHIRO;KAWADA, MIKIO;OTER+, TETRAHEDRON LETT., 1986, 27, N 5, 603-606
  作者：MANDAI, TADAKTSU、MORIYAMA, TADASHI、TSUJIMOTO, KOICHIRO、KAWADA, MIKIO、OTER+

  DOI：——

  日期：——
• CERAMIDE DERIVATIVES AS ANTICANCER AGENTS
  申请人：Rutgers, The State University of New Jersey

  公开号：US20180207123A1

  公开（公告）日：2018-07-26

  The invention provides a compound of formula (I): (I) wherein R 1 -R 4 have any of the values defined in the specification, as well as compositions comprising a compound of formula (I) and methods for treating diseases (e.g. cancer).
• CANNABINOID COMPOSITIONS WITH IMPROVED ORGANOLEPTIC AND THERAPEUTIC PROPERTIES, METHOD OF PRODUCTION, AND USE THEREOF
  申请人：CALIFORNIA AMBER INC.

  公开号：US20210068444A1

  公开（公告）日：2021-03-11

  Provided herein are compositions comprising cannabinoids, terpenoids, and other flavonoids. Also provided herein are methods for producing compositions comprising cannabinoids, terpenoids, and other flavonoids at industrial scale. In certain embodiments, the compositions provided herein possess desirable organoleptic properties and therapeutic effects when ingested or topically applied. In certain embodiments, the compositions of the present disclosure have are useful in inhalable, ingestible, or topical products to relieve and treat various acute or chronic illnesses.
• [EN] CANNABIN OID COMPOSITIONS WITH IMPROVED ORGANOLEPTIC AND THERAPEUTIC PROPERTIES, METHOD OF PRODUCTION, AND USE THEREOF<br/>[FR] COMPOSITIONS DE CANNABINOÏDES À PROPRIÉTÉS ORGANOLEPTIQUES ET THÉRAPEUTIQUES AMÉLIORÉES, LEUR PROCÉDÉ DE PRODUCTION ET LEUR UTILISATION
  申请人：CALIFORNIA AMBER INC

  公开号：WO2021050786A1

  公开（公告）日：2021-03-18

  Provided herein are compositions comprising cannabinoids, terpenoids, and other flavonoids. Also provided herein are methods for producing compositions comprising cannabinoids, terpenoids, and other flavonoids at industrial scale. In certain embodiments, the compositions provided herein possess desirable organoleptic properties and therapeutic effects when ingested or topically applied. In certain embodiments, the compositions of the present disclosure have are useful in inhalable, ingestible, or topical products to relieve and treat various acute or chronic illnesses.